USANA Health Sciences Inc (USNA) — Cash Flow-to-Debt Ratio
USANA Health Sciences Inc (USNA) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of $-3.39 Million could theoretically repay 0% of its total liabilities ($156.64 Million) in one year. See how much free cash does USANA Health Sciences Inc generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
USANA Health Sciences Inc Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for USANA Health Sciences Inc across 31 annual periods. Also explore net asset growth rate of USANA Health Sciences Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for USANA Health Sciences Inc (1995–2025)
Year-by-year debt coverage analysis for USANA Health Sciences Inc. For market capitalisation and broader financial context, see USANA Health Sciences Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | $22.35 Million | $156.64 Million | ▼ -62.1% |
| 2024 | 0.38x | $60.99 Million | $161.86 Million | ▼ -27.7% |
| 2023 | 0.52x | $70.64 Million | $135.56 Million | ▼ -18.7% |
| 2022 | 0.64x | $103.90 Million | $162.08 Million | ▼ -3.4% |
| 2021 | 0.66x | $121.23 Million | $182.62 Million | ▼ -17.5% |
| 2020 | 0.81x | $160.40 Million | $199.24 Million | ▲ +5.0% |
| 2019 | 0.77x | $126.73 Million | $165.22 Million | ▼ -17.6% |
| 2018 | 0.93x | $152.12 Million | $163.32 Million | ▲ +17.4% |
| 2017 | 0.79x | $123.78 Million | $156.06 Million | ▼ -15.9% |
| 2016 | 0.94x | $137.03 Million | $145.35 Million | ▲ +20.4% |
| 2015 | 0.78x | $111.47 Million | $142.38 Million | ▼ -10.4% |
| 2014 | 0.87x | $105.19 Million | $120.42 Million | ▼ -4.7% |
| 2013 | 0.92x | $98.89 Million | $107.95 Million | ▼ -19.3% |
| 2012 | 1.13x | $92.81 Million | $81.78 Million | ▲ +14.3% |
| 2011 | 0.99x | $70.11 Million | $70.59 Million | ▼ -11.9% |
| 2010 | 1.13x | $66.11 Million | $58.64 Million | ▲ +70.4% |
| 2009 | 0.66x | $32.47 Million | $49.06 Million | ▲ +30.7% |
| 2008 | 0.51x | $45.96 Million | $90.74 Million | ▼ -37.6% |
| 2007 | 0.81x | $57.22 Million | $70.49 Million | ▼ -46.6% |
| 2006 | 1.52x | $60.52 Million | $39.80 Million | ▼ -11.4% |
| 2005 | 1.72x | $48.02 Million | $27.97 Million | ▲ +7.1% |
| 2004 | 1.60x | $38.18 Million | $23.82 Million | ▼ -6.2% |
| 2003 | 1.71x | $35.48 Million | $20.76 Million | ▲ +125.4% |
| 2002 | 0.76x | $15.94 Million | $21.02 Million | ▲ +58.7% |
| 2001 | 0.48x | $9.95 Million | $20.83 Million | ▲ +165.7% |
| 2000 | 0.18x | $4.07 Million | $22.62 Million | ▼ -71.3% |
| 1999 | 0.63x | $15.00 Million | $23.90 Million | ▼ -44.3% |
| 1998 | 1.13x | $10.60 Million | $9.40 Million | ▲ +12.8% |
| 1997 | 1.00x | $7.10 Million | $7.10 Million | ▲ +107.1% |
| 1996 | 0.48x | $4.20 Million | $8.70 Million | ▼ -55.4% |
| 1995 | 1.08x | $3.90 Million | $3.60 Million | — |